{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:10:45Z","timestamp":1787605845921,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.oooo.2016.03.013","type":"journal-article","created":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T16:01:12Z","timestamp":1458748872000},"page":"e148-e153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Intraoral administration of botulinum toxin for trigeminal neuropathic pain"],"prefix":"10.1016","volume":"121","author":[{"given":"Alberto","family":"Herrero Babiloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia P.","family":"Kapos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Nixdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2016.03.013_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.oooo.2016.03.013_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: an overview and literature update","volume":"85","author":"Dworkin","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.oooo.2016.03.013_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2007\/730785","article-title":"Pharmacological management of chronic neuropathic pain\u2014consensus statement and guidelines from the Canadian Pain Society","volume":"12","author":"Moulin","year":"2007","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.oooo.2016.03.013_bib4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.oooo.2016.03.013_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3109\/15360288.2015.1037523","article-title":"Trigeminal neuralgia: unilateral episodic facial pain","volume":"29","author":"Zakrzewska","year":"2015","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.oooo.2016.03.013_bib6","first-page":"1207","article-title":"Trigeminal neuralgia","volume":"2014","author":"Zakrzewska","year":"2014","journal-title":"BMJ Clin Evid"},{"key":"10.1016\/j.oooo.2016.03.013_bib7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.oooo.2016.03.013_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.14219\/jada.archive.2000.0146","article-title":"Topical medications for orofacial neuropathic pain: a review","volume":"131","author":"Padilla","year":"2000","journal-title":"J\u00a0Am Dent Assoc"},{"key":"10.1016\/j.oooo.2016.03.013_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cden.2013.04.011","article-title":"Topical medications as treatment of neuropathic orofacial pain","volume":"57","author":"Nasri-Heir","year":"2013","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.oooo.2016.03.013_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/WNF.0b013e31829cb60e","article-title":"Acute treatment of trigeminal neuralgia with onabotulinum toxin A","volume":"36","author":"Zuniga","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.oooo.2016.03.013_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.oooo.2016.03.013_bib12","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3390\/toxins7083127","article-title":"Botulinum toxin for neuropathic pain: a review of the literature","volume":"7","author":"Oh","year":"2015","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.oooo.2016.03.013_bib13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00002826-200209000-00006","article-title":"Beneficial effects of botulinum toxin type A for patients with painful tic convulsif","volume":"25","author":"Micheli","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.oooo.2016.03.013_bib14","first-page":"21","article-title":"The use of botulinum toxin for the treatment of chronic facial pain","volume":"3","author":"Borodic","year":"2002","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.oooo.2016.03.013_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mds.21202","article-title":"Bilateral hemifacial spasm and trigeminal neuralgia: a unique form of painful tic convulsif","volume":"22","author":"Felicio","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.oooo.2016.03.013_bib16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.33588\/rn.4212.2006036","article-title":"Painful tic convulsif and botulinum toxin","volume":"42","author":"Bosca-Blasco","year":"2006","journal-title":"Rev Neurol"},{"key":"10.1016\/j.oooo.2016.03.013_bib17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1468-2982.2005.00959.x","article-title":"Botulinum toxin A for the treatment of greater occipital neuralgia and trigeminal neuralgia: a case report with pathophysiological considerations","volume":"26","author":"Volcy","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1016\/j.oooo.2016.03.013_bib18","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.tripleo.2009.03.021","article-title":"Injection of botulinum toxin type A (Botox) into trigger zone of trigeminal neuralgia as a means to control pain","volume":"109","author":"Ngeow","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2016.03.013_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s10194-007-0404-9","article-title":"An unusual case of vascular loop syndrome","volume":"8","author":"Uluduz","year":"2007","journal-title":"J\u00a0Headache Pain"},{"key":"10.1016\/j.oooo.2016.03.013_bib20","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","article-title":"Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial","volume":"72","author":"Yuan","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.oooo.2016.03.013_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.21601","article-title":"Sympathetic block with botulinum toxin to treat complex regional pain syndrome","volume":"65","author":"Carroll","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.oooo.2016.03.013_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1129-2377-14-72","article-title":"Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review","volume":"14","author":"Hu","year":"2013","journal-title":"J\u00a0Headache Pain"},{"key":"10.1016\/j.oooo.2016.03.013_bib23","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1590\/0004-282X20150109","article-title":"OnabotulinumtoxinA for trigeminal neuralgia: a review of the available data","volume":"73","author":"Kowacs","year":"2015","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.oooo.2016.03.013_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jama.2010.1937","article-title":"Terminology for preparations of botulinum neurotoxins: what a difference a name makes","volume":"305","author":"Albanese","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.oooo.2016.03.013_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2842.2011.02247.x","article-title":"Classifying orofacial pains: a new proposal of taxonomy based on ontology","volume":"39","author":"Nixdorf","year":"2012","journal-title":"J Oral Rehab"},{"key":"10.1016\/j.oooo.2016.03.013_bib26","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/AJP.0b013e31827eafff","article-title":"Subcutaneous and perineural botulinum toxin type A for neuropathic pain: a descriptive review","volume":"29","author":"Fabregat","year":"2013","journal-title":"Clin J Pain"},{"key":"10.1016\/j.oooo.2016.03.013_bib27","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1526-4637.2010.01003.x","article-title":"Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia","volume":"11","author":"Xiao","year":"2010","journal-title":"Pain Med"},{"key":"10.1016\/j.oooo.2016.03.013_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1129-2377-15-43","article-title":"Therapeutic effect of botulinum toxin A in 88 patients with trigeminal neuralgia with 14-month follow-up","volume":"15","author":"Li","year":"2014","journal-title":"J\u00a0Headache Pain"},{"key":"10.1016\/j.oooo.2016.03.013_bib29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2340\/00015555-0609","article-title":"Severe post-herpetic neuralgia successfully treated with botulinum toxin A: three case reports","volume":"89","author":"Sotiriou","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.oooo.2016.03.013_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1129-2377-15-65","article-title":"Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Zhang","year":"2014","journal-title":"J\u00a0Headache Pain"},{"key":"10.1016\/j.oooo.2016.03.013_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.wnf.0000172497.24770.b0","article-title":"Botulinum toxin and intractable trigeminal neuralgia","volume":"28","author":"Turk","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.oooo.2016.03.013_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tripleo.2010.04.043","article-title":"Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report","volume":"111","author":"Bohluli","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2016.03.013_bib33","first-page":"31","article-title":"Comparison and overview of currently available neurotoxins","volume":"7","author":"Walker","year":"2014","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"Suppl","key":"10.1016\/j.oooo.2016.03.013_bib34","first-page":"13","article-title":"Botulinum toxin type A reconstituted in lidocaine with epinephrine for facial rejuvenation: results of a participant satisfaction survey","author":"Kim","year":"2013","journal-title":"Cutis"},{"key":"10.1016\/j.oooo.2016.03.013_bib35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0025-6196(11)64616-8","article-title":"Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study","volume":"75","author":"Gassner","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.oooo.2016.03.013_bib36","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1365-2133.2007.07760.x","article-title":"Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study","volume":"156","author":"Vadoud-Seyedi","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.oooo.2016.03.013_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00002508-200503000-00010","article-title":"Injections of botulinum toxin type A produce pain alleviation in intractable trigeminal neuralgia","volume":"21","author":"Allam","year":"2005","journal-title":"Clin J Pain"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440316001085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440316001085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T22:51:04Z","timestamp":1748818264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440316001085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S2212440316001085"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2016.03.013","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraoral administration of botulinum toxin for trigeminal neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2016.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}